Fosun Pharma’s Global Ambitions: Innovation-Driven Expansion in 2025
Fosun Pharma; global expansion; innovative drugs; 2025 results; licensing deals
Novo Nordisk Foundation Commits Over $850M to Danish Life Science Incubator BII Over Next Decade
Novo Nordisk Foundation; BII; life science incubator; $850M; biotech startups; Denmark
Caldera Therapeutics Launches with $112.5M Funding for China-Licensed IBD Bispecific Antibody
Caldera Therapeutics; IBD; bispecific antibody; $112.5M funding; Qyuns Therapeutics; CLD-423
JPM26 Day 3: Sanofi CEO on RSV Scrutiny and Regeneron Dupixent Defense
JPM26; Sanofi; RSV; Beyfortus; Paul Hudson; FDA; vaccines; Dupixent; Regeneron
Cityblock Health Appoints New CTO and Tech-Focused Board Members to Accelerate AI-Driven Care
Cityblock Health; CTO; Alberto Lopez Toledo; board members; AI; Medicaid
Insilico Medicine Integrates Nach01 Foundation Model with Microsoft Discovery for AI-Native Drug Discovery
Insilico Medicine; Nach01; Microsoft Discovery; AI drug discovery; Azure; foundation model
FDA Requests Eli Lilly and Novo Nordisk to Remove Suicide Warnings from GLP-1 Drug Labels
FDA; GLP-1; suicide warnings; Eli Lilly; Novo Nordisk; Wegovy; Zepbound; Saxenda
Bristol Myers Squibb Completes $4.8 Billion Acquisition of Mirati Therapeutics
Bristol Myers Squibb; Mirati Therapeutics; acquisition; $4.8 billion; KRAZATI; oncology; KRAS G12C
Novo Nordisk Refocuses on Diabetes and Obesity to Expand GLP-1 Market at JPM26
Novo Nordisk; diabetes; obesity; GLP-1; JPM26; Mike Doustdar; Wegovy pill; semaglutide
JPM26: Novo Nordisk and Eli Lilly Compete Fiercely in Oral Obesity Treatments
Novo Nordisk; Eli Lilly; oral obesity drugs; JPM26; JPMHC; orglipron; semaglutide